peptideallianceStandard v1.1

Seller record · telehealth service · mangorx.com

MangoRx

A men's telehealth service selling oral semaglutide, testosterone and sexual health medications. Its terms name the pharmacy; its FAQ does not.

Passes 6 of 8 criteria. Recorded against Standard v1.1, August 2026.

Operating entity Mangoceuticals, Inc.

Dispositions at a glance

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSEvery healthcare provider from the third-party medical provider network is licensed in the United States, stated in the FAQ.Source: mangorx.com/faqs · read August 2026.
S2PASSThe order path was walked from the product page and stopped at account creation, which asks for a name and an email address.Source: mangorx.com/products/slim/get-started · read August 2026.
S3PASSThe terms name Epiq Scripts, LLC as the pharmacy providing prescription fulfillment; the FAQ describes it only as a Texas-based compounding pharmacy.Source: mangorx.com/terms-and-conditions · read August 2026.
S4PASSCompounded drugs are not FDA-approved and do not undergo pre-market review or safety testing, printed in the footer of every page.Source: mangorx.com · read August 2026.
S5FAILNo certificate, lot report or test document appears on the product page, the FAQ, the pharmacy disclaimer, or in the sitemap.Source: mangorx.com/sitemap.xml · read August 2026.
S6FAILFooter, contact, terms and privacy carry no street address; the terms state only that the service is operated from a Texas headquarters.Source: mangorx.com/terms-and-conditions, mangorx.com/privacy-policy, mangorx.com/contact-us · read August 2026.
S7PASSOral semaglutide, sold as Slim, is printed at 299 dollars on its public product page.Source: mangorx.com/products/slim · read August 2026.
S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index · read August 2026.

Products shown on the seller's own pages at the recorded date: oral semaglutide, testosterone, sildenafil, tadalafil, finasteride, minoxidil, sermorelin, NAD+.

Dispositions recorded against Standard v1.1, August 2026. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.